2026 BD opportunity scan for Kimera Labs, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Karuna Therapeutics, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Kallyope, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for JYAMS PET Research & Development Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach

2026 BD opportunity scan for Jonsson Comprehensive Cancer Center: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach ra

2026 BD opportunity scan for Jiangxi Shimei Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreac

2026 BD opportunity scan for Jiangxi Qingfeng Pharmaceutical Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outrea

2026 BD opportunity scan for Jiangxi Jemincare Group Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rati

2026 BD opportunity scan for Jiangxi Huiren Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreac

2026 BD opportunity scan for Jiangsu Zhongxin Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre

2026 BD opportunity scan for Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signal

2026 BD opportunity scan for Jiangsu Vcare PharmaTech Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rat